Publication | Open Access
Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study
106
Citations
28
References
2014
Year
ClinicalTrials.gov NCT00573326. Registered 13 December 2007.
| Year | Citations | |
|---|---|---|
Page 1
Page 1